Drug Profile
GTP 200
Alternative Names: GTP-200Latest Information Update: 03 Feb 2020
Price :
$50
*
At a glance
- Originator Gastrotech Pharma
- Class Peptide hormones
- Mechanism of Action Growth hormone releasing factor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cachexia
Most Recent Events
- 03 Feb 2020 Discontinued - Phase-II for Cachexia in Sweden (IV)
- 07 Jan 2020 Discontinued - Phase-I/II for Cachexia in Switzerland (IV)
- 13 Feb 2006 Phase-II clinical trials in Cachexia in Sweden (IV)